These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22033657)

  • 1. Cellular plasticity and resilience and the pathophysiology of severe mood disorders.
    Charney DS; Dejesus G; Manji HK
    Dialogues Clin Neurosci; 2004 Jun; 6(2):217-25. PubMed ID: 22033657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets.
    Carlson PJ; Singh JB; Zarate CA; Drevets WC; Manji HK
    NeuroRx; 2006 Jan; 3(1):22-41. PubMed ID: 16490411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis C, interferon a and depression: main physiopathologic hypothesis].
    Vignau J; Karila L; Costisella O; Canva V
    Encephale; 2005; 31(3):349-57. PubMed ID: 16142050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroplasticity and depression].
    Czéh B; Simon M
    Psychiatr Hung; 2005; 20(1):4-17. PubMed ID: 16389729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroplasticity in mood disorders.
    Drevets WC
    Dialogues Clin Neurosci; 2004 Jun; 6(2):199-216. PubMed ID: 22033747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.
    Manji HK; Quiroz JA; Sporn J; Payne JL; Denicoff K; A Gray N; Zarate CA; Charney DS
    Biol Psychiatry; 2003 Apr; 53(8):707-42. PubMed ID: 12706957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of neuroplasticity in depression: the hippocampus and beyond.
    Fuchs E; Czéh B; Kole MH; Michaelis T; Lucassen PJ
    Eur Neuropsychopharmacol; 2004 Dec; 14 Suppl 5():S481-90. PubMed ID: 15550346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroplasticity and cellular resilience in mood disorders.
    Manji HK; Moore GJ; Rajkowska G; Chen G
    Mol Psychiatry; 2000 Nov; 5(6):578-93. PubMed ID: 11126389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor trafficking.
    Du J; Quiroz JA; Gray NA; Szabo ST; Zarate CA; Manji HK
    Dialogues Clin Neurosci; 2004 Jun; 6(2):143-55. PubMed ID: 22034247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of pharmacological and epigenetic factors to suppress neurotrophic factors and enhance neural plasticity in stress and mood disorders.
    Tarai S; Mukherjee R; Gupta S; Rizvanov AA; Palotás A; Chandrasekhar Pammi VS; Bit A
    Cogn Neurodyn; 2019 Jun; 13(3):219-237. PubMed ID: 31168328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system.
    Zarate CA; Du J; Quiroz J; Gray NA; Denicoff KD; Singh J; Charney DS; Manji HK
    Ann N Y Acad Sci; 2003 Nov; 1003():273-91. PubMed ID: 14684452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders.
    Quiroz JA; Manji HK
    Dialogues Clin Neurosci; 2002 Mar; 4(1):73-92. PubMed ID: 22034240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma.
    Nazlı ŞB; Sevindik M
    Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Novel Treatments for Severe Mood Disorders Involving Cellular Plasticity Cascades.
    Machado-Vieira R; Zarate CA; Manji HK
    Curr Psychos Ther Rep; 2006 Dec; 4(4):181-190. PubMed ID: 25620894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.
    Quiroz JA; Singh J; Gould TD; Denicoff KD; Zarate CA; Manji HK
    Mol Psychiatry; 2004 Aug; 9(8):756-76. PubMed ID: 15136795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.
    Sanacora G; Treccani G; Popoli M
    Neuropharmacology; 2012 Jan; 62(1):63-77. PubMed ID: 21827775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
    Manji HK; Duman RS
    Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses.
    Du J; Quiroz J; Yuan P; Zarate C; Manji HK
    Neuron Glia Biol; 2004 Aug; 1(3):231-43. PubMed ID: 18634600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of DA D3 Receptors in Structural Neuroplasticity of Selected Limbic Brain Circuits: Possible Role in Treatment-Resistant Depression.
    Merlo Pich E; Cavalleri L; Toma C; Collo G
    Curr Top Behav Neurosci; 2023; 60():73-87. PubMed ID: 35538302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.